LINDSEY WINFIELD: Open Payments
NPI 1366825523 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,304 in 135 payments from 18 companies in 2025. Trend: 2023 $1,667 · 2024 $1,924 · 2025 $2,304
Food & beverage: $2,304
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $555 |
| PFIZER INC. | 28 | $338 |
| Novo Nordisk Inc | 19 | $316 |
| Medtronic, Inc. | 1 | $171 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $164 |
| Lilly USA, LLC | 9 | $130 |
| GlaxoSmithKline, LLC. | 7 | $119 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $75 |
| Otsuka America Pharmaceutical, Inc. | 3 | $71 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $66 |
Products named: VRAYLAR, NURTEC ODT, UBRELVY, SYMPLICITY G3, CAPLYTA, Wegovy, Ozempic, MOUNJARO.
Industry payments across KY — which companies pay providers there.
